Stem cell therapy for chronic myocardial infarction

Journal of Cardiovascular Translational Research

Volumn 3, Issue 2, 2010, Pages 79-88

  Mazo, Manuel ^a   Pelacho, Beatriz ^a   Prósper, Felipe ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Animal models; Chronic myocardial infarction; Stem cell

Indexed keywords

ADIPOSE TISSUE; BONE MARROW; CELL TYPE; CHRONIC DISEASE; DISEASE MODEL; ENDOTHELIUM CELL; FUNCTIONAL ASSESSMENT; HEART INFARCTION; HEMATOPOIETIC STEM CELL; MESENCHYMAL STEM CELL; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE; STEM CELL TRANSPLANTATION; TISSUE REGENERATION; UMBILICAL CORD BLOOD; ANIMAL; CONVALESCENCE; HEART CONTRACTION; HEART MUSCLE; HUMAN; MYOCARDIAL INFARCTION; PATHOLOGY; PATHOPHYSIOLOGY; REGENERATION; TIME; TREATMENT OUTCOME;

ANIMALS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; HUMANS; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIUM; RECOVERY OF FUNCTION; REGENERATION; STEM CELL TRANSPLANTATION; TIME FACTORS; TREATMENT OUTCOME;

ANIMALIA;

EID: 77953620194     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-009-9159-9     Document Type: Review

References (90)

1. Adamopoulos, S., Parissis, J. T., & Kremastinos, D. T. (2001). A glossary of circulating cytokines in chronic heart failure. European Journal of Heart Failure, 3, 517-526.
2. Agbulut, O., Mazo, M., Bressolle, C., Gutierrez, M., Azarnoush, K., Sabbah, L., et al. (2006). Can bone marrow-derived multipotentadult progenitor cells regenerate infarcted myocardium?Cardiovascular Research, 72, 175-183.
3. Armstrong, P.W., Granger, C. B., Adams, P. X., Hamm, C., Holmes, D., Jr., O'Neill, W. W., et al. (2007). Pexelizumab for acute STelevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: A randomized controlled trial.JAMA, 297, 43-51.
4. Bai, X., Pinkernell, K., Song, Y. H., Nabzdyk, C., Reiser, J., & Alt, E. (2007). Genetically selected stem cells from human adipose tissue express cardiac markers. Biochemical and Biophysical Research Communications, 353, 665-671.
5. Behfar, A., Faustino, R. S., Arrell, D. K., Dzeja, P. P., Perez-Terzic, C., & Terzic, A. (2008). Guided stem cell cardiopoiesis: Discovery and translation. Journal of Molecular and CellularCardiology, 45, 523-529.
6. Bonaros, N., Rauf, R., Werner, E., Schlechta, B., Rohde, E., Kocher, A., et al. (2008). Neoangiogenesis after combined transplantation of skeletal myoblasts and angiopoietic progenitors leads to increased cell engraftment and lower apoptosis rates in ischemic heart failure. Interact Cardiovasc Thorac Surg, 7, 249-255.
7. Bonaros, N., Rauf, R., Wolf, D., Margreiter, E., Tzankov, A.,Schlechta, B., et al. (2006). Combined transplantation of skeletal myoblasts and angiopoietic progenitor cells reduces infarct size and apoptosis and improves cardiac function in chronic ischemic heart failure. Journal of Thoracic and Cardiovascular Surgery, 132, 1321-1328.
8. Breitbach, M., Bostani, T., Roell, W., Xia, Y., Dewald, O., Nygren, J. M., et al. (2007). Potential risks of bone marrow cell transplantation into infarcted hearts. Blood, 110, 1362-1369.
9. Bujak, M. & Frangogiannis, N. G. (2007). The role of TGF-beta signaling in myocardial infarction and cardiac remodeling.Cardiovascular Research, 74, 184-195.
10. Caspi, O., Huber, I., Kehat, I., Habib, M., Arbel, G., Gepstein, A., et al. (2007). Transplantation of human embryonic stem cellderived cardiomyocytes improves myocardial performance in infarcted rat hearts. Journal of the American College of Cardiology, 50, 1884-1893.
11. Cleutjens, J. P., Kandala, J. C., Guarda, E., Guntaka, R. V., & Weber, K. T. (1995). Regulation of collagen degradation in the rat myocardium after infarction. Journal of Molecular and Cellular Cardiology, 27, 1281-1292.
12. Chang, S. A., Lee, E. J., Kang, H. J., Zhang, S. Y., Kim, J. H., Li, L., et al. (2008). Impact of myocardial infarct proteins and oscillating pressure on the differentiation of mesenchymal stem cells: Effect of acute myocardial infarction on stem cell differentiation. Stem Cells, 26, 1901-1912.
13. Desmouliere, A., Chaponnier, C., & Gabbiani, G. (2005). Tissue repair, contraction, and the myofibroblast. Wound Repair and Regeneration, 13, 7-12.
14. Deten, A., Volz, H. C., Briest, W., & Zimmer, H. G. (2002). Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental studies in rats. Cardiovascular Research, 55, 329-340.
15. Ertl, G. & Frantz, S. (2005). Healing after myocardial infarction. Cardiovascular Research, 66, 22-32.
16. Farahmand, P., Lai, T. Y., Weisel, R. D., Fazel, S., Yau, T., Menasche, P., et al. (2008). Skeletal myoblasts preserve remote matrix architecture and global function when implanted early or late after coronary ligation into infarcted or remote myocardium. Circulation, 118, S130-137.
17. Fishbein, M. C., Maclean, D., & Maroko, P. R. (1978). Experimental myocardial infarction in the rat: Qualitative and quantitative changes during pathologic evolution. American Journal of Pathology, 90, 57-70.
18. Frangogiannis, N. G., Perrard, J. L., Mendoza, L. H., Burns, A. R., Lindsey, M. L., Ballantyne, C. M., et al. (1998). Stem cell factor induction is associated with mast cell accumulation after canine myocardial ischemia and reperfusion. Circulation, 98, 687-698.
19. Frangogiannis, N. G., Smith, C. W., & Entman, M. L. (2002). The inflammatory response in myocardial infarction. Cardiovascular Research, 53, 31-47.
20. Fukushima, S., Coppen, S. R., Lee, J., Yamahara, K., Felkin, L.E., Terracciano, C. M., et al. (2008). Choice of cell-delivery route for skeletal myoblast transplantation for treating post-infarction chronic heart failure in rat. PLoS ONE, 3, e3071.
21. Fyhrquist, F. & Saijonmaa, O. (2008). Renin-angiotensin system revisited. Journal of Internal Medicine, 264, 224-236.
22. Gavira, J. J., Herreros, J., Perez, A., Garcia-Velloso, M. J., Barba, J., Martin-Herrero, F., et al. (2006). Autologous skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1-year follow-up. Journal of Thoracic and Cardiovascular Surgery, 131, 799-804.
23. Gavira, J. J., Nasarre, E., Abizanda, G., Perez-Ilzarbe, M., de Martino-Rodriguez, A., Garcia de Jalon, J. A. et al. (2009). Repeated implantation of skeletal myoblast in a swine model of chronic myocardial infarction. European Heart Journal (in press).
24. Gavira, J. J., Perez-Ilzarbe, M., Abizanda, G., Garcia-Rodriguez, A., Orbe, J., Paramo, J. A., et al. (2006). A comparison between percutaneous and surgical transplantation of autologous skeletal myoblasts in a swine model of chronic myocardial infarction. Cardiovascular Research, 71, 744-753.
25. Hamad, E., Mather, P. J., Srinivasan, S., Rubin, S., Whellan, D. J., & Feldman, A. M. (2007). Pharmacologic therapy of chronic heart failure. American Journal of Cardiovascular Drugs, 7, 235-248.
26. He, Q., Trindade, P. T., Stumm, M., Li, J., Zammaretti, P., Bettiol, E., et al. (2009). Fate of undifferentiated mouse embryonic stem cells within the rat heart: Role of myocardial infarction and immune suppression. Journal of Cellular and Molecular Medicine, 13, 188-201.
27. Holmes, J. W., Borg, T. K., & Covell, J. W. (2005). Structure and mechanics of healing myocardial infarcts. Annual Review of Biomedical Engineering, 7, 223-253.
28. Irwin, M. W., Mak, S., Mann, D. L., Qu, R., Penninger, J. M., Yan, A., et al. (1999). Tissue expression and immunolocalization of tumor necrosis factor-alpha in postinfarction dysfunctional myocardium. Circulation, 99, 1492-1498.
29. Kastrup, J., Ripa, R. S., Wang, Y., & Jorgensen, E. (2006). Myocardial regeneration induced by granulocyte-colonystimulating factor mobilization of stem cells in patients with acute or chronic ischaemic heart disease: A non-invasive alternative for clinical stem cell therapy? European Heart Journal, 27, 2748-2754.
30. Kinnaird, T., Stabile, E., Burnett, M. S., Lee, C. W., Barr, S., Fuchs, S., et al. (2004). Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circulation Research, 94, 678-685.
31. Koh, G. Y., Klug, M. G., Soonpaa, M. H., & Field, L. J. (1993). Differentiation and long-term survival of C2C12 myoblast grafts in heart. Journal of Clinical Investigation, 92, 1548-1554.
32. Laflamme, M. A., Chen, K. Y., Naumova, A. V., Muskheli, V., Fugate, J. A., Dupras, S. K., et al. (2007). Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nature Biotechnology, 25, 1015-1024.
33. Landa, N., Miller, L., Feinberg, M. S., Holbova, R., Shachar, M., Freeman, I., et al. (2008). Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. Circulation, 117, 1388-1396.
34. Le Blanc, K. (2006). Mesenchymal stromal cells: Tissue repair and immune modulation. Cytotherapy, 8, 559-561.
35. Leobon, B., Roncalli, J., Joffre, C., Mazo, M., Boisson, M., Barreau, C., et al. (2009). Adipose-derived cardiomyogenic cells: In vitro expansion and functional improvement in a mouse model of myocardial infarction. Cardiovascular Research, 83, 757-767.
36. Li, L., Zhang, S., Zhang, Y., Yu, B., Xu, Y., & Guan, Z. (2008). Paracrine action mediate the antifibrotic effect of transplanted mesenchymal stem cells in a rat model of global heart failure. Molecular Biology Reports, 36, 725-731.
37. Li, R. K., Mickle, D. A., Weisel, R. D., Rao, V., & Jia, Z. Q. (2001). Optimal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury. Annals of Thoracic Surgery, 72, 1957-1963.
38. Li, S. H., Lai, T. Y., Sun, Z., Han, M., Moriyama, E., Wilson, B., et al. (2009). Tracking cardiac engraftment and distribution of implanted bone marrow cells: Comparing intra-aortic, intravenous, and intramyocardial delivery. Journal of Thoracic and Cardiovascular Surgery, 137, 1225-1233. e1221.
39. Liu, J. F., Wang, B. W., Hung, H. F., Chang, H., & Shyu, K. G. (2008). Human mesenchymal stem cells improve myocardial performance in a splenectomized rat model of chronic myocardial infarction. Journal of the Formosan Medical Association, 107, 165-174.
40. Mann, D. L. (1999). Mechanisms and models in heart failure: A combinatorial approach. Circulation, 100, 999-1008.
41. Mann, D. L., Deswal, A., Bozkurt, B., & Torre-Amione, G. (2002). New therapeutics for chronic heart failure. Annual Review of Medicine, 53, 59-74.
42. Martinez-Fernandez, A., Nelson, T. J., Yamada, S., Reyes, S., Alekseev, A. E., Perez-Terzic, C., et al. (2009). iPS programmedwithout c-MYC yield proficient cardiogenesis for functional heart chimerism. Circulation Research, 105, 648-656.
43. Mauritz, C., Schwanke, K., Reppel, M., Neef, S., Katsirntaki, K., Maier, L. S., et al. (2008). Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation, 118, 507-517.
44. Mazo, M. (2009). Transplantation of mesenchymal stem cells exerts a greater long-term effect than bone marrow mononuclear cells in a chronic myocardial infarction model in rat. Cell Transplant. doi:10.3727/ 096368909X480323.
45. Mazo, M., Planat-Benard, V., Abizanda, G., Pelacho, B., Leobon, B., Gavira, J. J., et al. (2008). Transplantation of adipose derived stromal cells is associated with functional improvement in a rat model of chronic myocardial infarction. European Journal of Heart Failure, 10, 454-462.
46. Menasche, P. (2009). Stem cell therapy for heart failure: Are arrhythmias a real safety concern? Circulation, 119, 2735-2740.
47. Menasche, P., Alfieri, O., Janssens, S., McKenna, W., Reichenspurner, H., Trinquart, L., et al. (2008). The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Trial: First randomized placebo-controlled study of myoblast transplantation. Circulation, 117, 1189-1200.
48. Merx, M. W., Zernecke, A., Liehn, E. A., Schuh, A., Skobel, E., Butzbach, B., et al. (2005). Transplantation of human umbilical vein endothelial cells improves left ventricular function in a rat model of myocardial infarction. Basic Research in Cardiology, 100, 208-216.
49. Mias, C., Lairez, O., Trouche, E., Roncalli, J., Calise, D., Seguelas, M. H. et al. (2009). Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction. Stem Cells, 27(11), 2734-2743.
50. Miranville, A., Heeschen, C., Sengenes, C., Curat, C. A., Busse, R., & Bouloumie, A. (2004). Improvement of postnatal neovascularization by human adipose tissue-derived stem cells. Circulation, 110, 349-355.
51. Miyahara, Y., Nagaya, N., Kataoka, M., Yanagawa, B., Tanaka, K., Hao, H., et al. (2006). Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nature Medicine, 12, 459-465.
52. Nahrendorf, M., Swirski, F. K., Aikawa, E., Stangenberg, L., Wurdinger, T., Figueiredo, J. L., et al. (2007). The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. Journal of Experimental Medicine, 204, 3037-3047.
53. Nakajima, H., Sakakibara, Y., Tambara, K., Marui, A., Yoshimoto, M., Premaratne, G. U., et al. (2008). Delivery route in bone marrow cell transplantation should be optimized according to the etiology of heart disease. Circ J, 72, 1528-1535.
54. Nelson, T. J., Martinez-Fernandez, A., Yamada, S., Perez-Terzic, C., Ikeda, Y., Terzic, A. (2009) Repair of acute myocardial infarction with induced pluripotent stem cells induced by human stemness factors. Circulation. doi:10.1161/CIRCULATIONAHA.109.865154.
55. Nian, M., Lee, P., Khaper, N., & Liu, P. (2004). Inflammatory cytokines and postmyocardial infarction remodeling. Circulation Research, 94, 1543-1553.
56. Nussbaum, J., Minami, E., Laflamme, M. A., Virag, J. A., Ware, C. B., Masino, A., et al. (2007). Transplantation of undifferentiated murine embryonic stem cells in the heart: Teratoma formation and immune response. FASEB Journal, 21, 1345-1357.
57. Organization WH (2004) The world health report 2004.
58. Orlic, D., Kajstura, J., Chimenti, S., Bodine, D. M., Leri, A., & Anversa, P. (2001). Transplanted adult bone marrow cells repair myocardial infarcts in mice. Annals of the New York Academy of Sciences, 938, 221-229. discussion 229-230.
59. Orlic, D., Kajstura, J., Chimenti, S., Jakoniuk, I., Anderson, S. M., Li, B., et al. (2001). Bone marrow cells regenerate infarcted myocardium. Nature, 410, 701-705.
60. Ott, H. C., Matthiesen, T. S., Goh, S. K., Black, L. D., Kren, S. M., Netoff, T. I., et al. (2008). Perfusion-decellularized matrix: Using nature's platform to engineer a bioartificial heart. Nature Medicine, 14, 213-221.
61. Pearl, J. & Wu, J. C. (2008). Seeing is believing: Tracking cells to determine the effects of cell transplantation. Seminars in Thoracic and Cardiovascular Surgery, 20, 102-109.
62. Pelacho, B. & Prosper, F. (2008). Stem cells and cardiac disease: Where are we going? Curr Stem Cell Res Ther, 3, 265-276.
63. Perez-Ilzarbe, M., Agbulut, O., Pelacho, B., Ciorba, C., San, Jose-Eneriz E., Desnos, M., et al. (2008). Characterization of the paracrine effects of human skeletal myoblasts transplanted in infarcted myocardium. European Journal of Heart Failure, 10, 1065-1072.
64. Pfannkuche, K., Liang, H., Hannes, T., Xi, J., Fatima, A., Nguemo, F., et al. (2009). Cardiac myocytes derived from murine reprogrammed fibroblasts: Intact hormonal regulation, cardiac ion channel expression and development of contractility. Cellular Physiology and Biochemistry, 24, 73-86.
65. Phillips, H. R., O'Connor, C. M., & Rogers, J. (2007). Revascularization for heart failure. American Heart Journal, 153, 65-73.
66. Planat-Benard, V., Menard, C., Andre, M., Puceat, M., Perez, A., Garcia-Verdugo, J. M., et al. (2004). Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circulation Research, 94, 223-229.
67. Puymirat, E., Geha, R., Tomescot, A., Bellamy, V., Larghero, J., Trinquart, L., et al. (2009). Can mesenchymal stem cells induce tolerance to cotransplanted human embryonic stem cells? Molecular Therapy, 17, 176-182.
68. Richard, V., Murry, C. E., & Reimer, K. A. (1995). Healing of myocardial infarcts in dogs. Effects of late reperfusion. Circulation, 92, 1891-1901.
69. Roger, V. L., Weston, S. A., Redfield, M. M., Hellermann-Homan, J. P., Killian, J., Yawn, B. P., et al. (2004). Trends in heart failure incidence and survival in a community-based population. Jama, 292, 344-350.
70. Rossen, R. D., Michael, L. H., Kagiyama, A., Savage, H. E., Hanson, G., Reisberg, M. A., et al. (1988). Mechanism of complement activation after coronary artery occlusion: Evidence that myocardial ischemia in dogs causes release of constituents of myocardial subcellular origin that complex with human C1q in vivo. Circulation Research, 62, 572-584.
71. Rota, M., Kajstura, J., Hosoda, T., Bearzi, C., Vitale, S., Esposito, G., et al. (2007). Bone marrow cells adopt the cardiomyogenic fate in vivo. Proceedings of the National Academy of Sciences of the United States of America, 104, 17783-17788.
72. Schaffler, A. & Buchler, C. (2007). Concise review: Adipose tissue-derived stromal cells-Basic and clinical implications for novel cell-based therapies. Stem Cells, 25, 818-827.
73. Schuleri, K. H., Feigenbaum, G. S., Centola, M., Weiss, E. S., Zimmet, J. M., Turney, J., et al. (2009). Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy. European Heart Journal, 30, 2722-2732.
74. Segers, V. F. & Lee, R. T. (2008). Stem-cell therapy for cardiac disease. Nature, 451, 937-942.
75. Shanmugam, G. & Legare, J. F. (2008). Revascularization for ischaemic cardiomyopathy. Current Opinion in Cardiology, 23, 148-152.
76. Shintani, Y., Fukushima, S., Varela-Carver, A., Lee, J., Coppen, S. R., Takahashi, K., et al. (2009). Donor cell type-specific paracrine effects of cell transplantation for post-infarction heart failure. Journal of Molecular and Cellular Cardiology, 47, 288-295.
77. Silva, G. V., Litovsky, S., Assad, J. A., Sousa, A. L., Martin, B. J., Vela, D., et al. (2005). Mesenchymal stem cells differentiate into heart function in a canine chronic ischemia model. Circulation, 111, 150-156.
78. Strem, B. M., Hicok, K. C., Zhu, M., Wulur, I., Alfonso, Z., Schreiber, R. E., et al. (2005). Multipotential differentiation of adipose tissue-derived stem cells. Keio Journal of Medicine, 54, 132-141.
79. Sun, Y., Kiani, M. F., Postlethwaite, A. E., & Weber, K. T. (2002). Infarct scar as living tissue. Basic Research in Cardiology, 97, 343-347.
80. Takahashi, K. & Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126, 663-676.
81. Takehara, N., Tsutsumi, Y., Tateishi, K., Ogata, T., Tanaka, H., Ueyama, T., et al. (2008). Controlled delivery of basic fibroblast growth factor promotes human cardiosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarction. J Am Coll Cardiol, 52, 1858-1865.
82. Taylor, D. A., Atkins, B. Z., Hungspreugs, P., Jones, T. R., Reedy, M. C., Hutcheson, K. A., et al. (1998). Regenerating functional myocardium: Improved performance after skeletal myoblast transplantation. Nature Medicine, 4, 929-933.
83. van Amerongen, M. J., Bou-Gharios, G., Popa, E., van Ark, J., Petersen, A. H., van Dam, G. M., et al. (2008). Bone marrowderived myofibroblasts contribute functionally to scar formation after myocardial infarction. J Pathol, 214, 377-386.
84. Vandervelde, S., van Amerongen, M. J., Tio, R. A., Petersen, A. H., van Luyn, M. J., & Harmsen, M. C. (2006). Increased inflammatory response and neovascularization in reperfused vs. non-reperfused murine myocardial infarction. Cardiovasc Pathol, 15, 83-90.
85. Virag, J. I. & Murry, C. E. (2003). Myofibroblast and endothelial cell proliferation during murine myocardial infarct repair. American Journal of Pathology, 163, 2433-2440.
86. Waksman, R., Fournadjiev, J., Baffour, R., Pakala, R., Hellinga, D., Leborgne, L., et al. (2004). Transepicardial autologous bone marrow-derived mononuclear cell therapy in a porcine model of chronically infarcted myocardium. Cardiovasc Radiat Med, 5, 125-131.
87. Weisman, H. F., Bush, D. E., Mannisi, J. A., Weisfeldt, M. L., & Healy, B. (1988). Cellular mechanisms of myocardial infarct expansion. Circulation, 78, 186-201.
88. Yu, J., Christman, K. L., Chin, E., Sievers, R. E., Saeed, M., & Lee, R. J. (2009). Restoration of left ventricular geometry and improvement of left ventricular function in a rodent model of chronic ischemic cardiomyopathy. Journal of Thoracic and Cardiovascular Surgery, 137, 180-187.
89. Yu, J., Gu, Y., Du, K. T., Mihardja, S., Sievers, R. E., & Lee, R. J. (2008). The effect of injected RGD modified alginate on angiogenesis and left ventricular function in a chronic rat infarct model. Biomaterials, 30, 751-756.
90. Zhang, J., Wilson, G. F., Soerens, A. G., Koonce, C. H., Yu, J., Palecek, S. P., et al. (2009). Functional cardiomyocytes derived from human induced pluripotent stem cells. Circulation Research, 104, e30-41.